Regeneron

YTD

ALL

Trade Regeneron 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About REGN

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.

CEO

Leonard S. Schleifer

CEOLeonard S. Schleifer

Employees

15,106

Employees15,106

Headquarters

Tarrytown, New York

HeadquartersTarrytown, New York

Founded

1988

Founded1988

Employees

15,106

Employees15,106

REGN Key Statistics

Market cap

60.38B

Market cap60.38B

Price-Earnings ratio

13.88

Price-Earnings ratio13.88

Dividend yield

0.32%

Dividend yield0.32%

Average volume

906.07K

Average volume906.07K

High today

$583.28

High today$583.28

Low today

$542.89

Low today$542.89

Open price

$583.01

Open price$583.01

Volume

1.63M

Volume1.63M

52 Week high

$1,211.20

52 Week high$1,211.20

52 Week low

$476.49

52 Week low$476.49

REGN News

Seeking Alpha 12h

Regeneron posts Q2 beat as new Eylea version outperforms

Regeneron Pharmaceuticals (NASDAQ:REGN) on Friday topped Street forecasts with its Q2 financials, thanks mainly to U.S. sales for its newly developed high-dose...

Analyst ratings

71%

of 28 ratings

Buy

71.4%

Hold

25%

Sell

3.6%

People also own

Based on the portfolios of people who own REGN. This list is generated using Robinhood data, and it’s not a recommendation.